Summary of Purpose
This study aims to estimate the costs of botulinum toxin A utilization in standard practice for the treatment of upper limb spasticity post-stroke in Portugal. It will consider the three most used locally available brands of botulinum toxin A which show similar efficacy and safety profiles thus making it relevant to understand if choosing between one or another brand can depend directly on economic factors. ...Read More →
The following dates are available for this trial. Trial information last updated on 22 December 2017.
|1 Nov 2014||4 Mar 2015||16 Mar 2017||16 Mar 2017||1 Dec 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Case-Only
- Sampling: Non-Probability Sample
- Ipsen Recruitment Enquiries